Skip to main content
Premium Trial:

Request an Annual Quote

Open Access Someday

Open access to scientific papers will occur eventually, says Philip Campbell, editor-in-chief of Nature, The Guardian reports. "My personal belief is that that's what's going to happen in the long run," Campbell said at session on open access at the Science Media Centre. Campbell added that he has found that reading and researching open-access papers has been a "very compelling" experience. However, Campbell noted that if gold-level open access — in which authors pay a fee to have their work made freely available immediately — becomes common, it could cost more than $10,000 to publish an article in Nature or some other prestigious journals.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.